Journal profile · Medicine-Ophthalmology
Current Ophthalmology Reports
ISSN 2167-4868 · Springer Nature · 4 issues per year
Current Ophthalmology Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.5 (journal website); hybrid open access; APC about USD 4,190; median 94 days to acceptance (21 articles, last 24 months); 15 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Ophthalmology Reports is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Corneal surgery and disorders and Retinal Diseases and Treatments, together about 34.3% of its articles. Its main subfields are Ophthalmology and Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
This journal aims to offer expert review articles on the most significant recent developments in the field of ophthalmology. By providing clear, insightful, balanced contributions, the journal intends to serve those who diagnose, treat, manage, and prevent ocular conditions and diseases. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of more than 20 internationally diverse members reviews the annual table of contents, ensures that topics include emerging research, and suggests topics of special importance to their country/region. Topics covered may include age-related macular degeneration; diabetic retinopathy; dry eye syndrome; glaucoma; pediatric ophthalmology; ocular infections; refractive surgery; and stem cell therapy.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Ophthalmology
Editor-in-chief Victor L. PerezPublisher website
Editorial board by country: none in mainland China; most named United States 16, Brazil 3, Spain 2, Japan 1, India 1 (30 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glaucoma and retinal disordersMedicine12.3%
- Corneal surgery and disordersMedicine11.7%
- Retinal Diseases and TreatmentsMedicine10.2%
- Ocular Surface and Contact LensMedicine10.2%
- Corneal Surgery and TreatmentsMedicine8.8%
- Intraocular Surgery and LensesMedicine6.1%
- Ocular Infections and TreatmentsMedicine5.2%
- Retinal Imaging and AnalysisMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.5Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.74LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 88OpenAlex ·
- 2-year mean citedness
- 2.3OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 38.89%LetPub ·
Volume
- Articles per year
- 15LetPub ·
- Downloads per year (publisher) 2025
- 71,000Publisher website ·
Articles by year OpenAlex count · 355 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 15 | 9 | 2 |
| 2025 | 15 | 9 | 38 |
| 2024 | 7 | 4 | 45 |
| 2023 | 14 | 5 | 56 |
| 2022 | 26 | 4 | 136 |
| 2021 | 21 | 10 | 186 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
94 daysMedian, submission to acceptance · P25–P75 65 days – 138 days
- Acceptance to online
- median 32 days (31 articles)
- Submission to online
- median 135 days
- Sample
- 21 articles with submission and acceptance dates (31 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 9 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,190 / EUR 3,190 / GBP 2,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Conflict of interest
Competing interests disclosure required Model summary
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list. If no conflict exists, authors should state: The authors declare that they have no conflict of interest. Back to top
Source ↗Publisher website ·- Data availability Data availability statements
Data transparency requested Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Ethical standards
Ethics approval required for human/animal studies Model summary
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
Source ↗Publisher website ·- License & copyright Copyright
Permissions required for previously published material Model summary
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Current Ophthalmology Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 2167-4868
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Ophthalmology Reports
What CAS zone is Current Ophthalmology Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Ophthalmology Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Ophthalmology Reports?
The journal's website gives an impact factor of 1.5 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 2.1, h-index 27.
How long does peer review take at Current Ophthalmology Reports?
Based on the dates recorded on 21 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 65–138 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Ophthalmology Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Ophthalmology Reports based?
Of the 30 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (16), Brazil (3) and Spain (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Ophthalmology Reports?
According to LetPub and DOAJ records, Current Ophthalmology Reports is indexed in ESCI and Scopus. The journal's website also lists Embase; that list has not been checked against each database.
Is Current Ophthalmology Reports open access, and what is the APC?
Current Ophthalmology Reports is a hybrid journal. For open-access publication: APC about USD 4,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .